{"id":"b8afe0c0-ebd1-41ca-b8e9-91a9fae2e0f2","arxiv_id":"2605.29210","paper_version":1,"verdict":"UNVERDICTED","confidence":"LOW","novelty_score":7.0,"correctness_risk":"high","formal_verification":"none","parameter_count":0,"one_line_summary":"SAMD automates STPA-Sec modeling of AI/ML medical devices as control structures to generate false data injection attack scenarios via LLMs and vulnerability data, evaluated on five FDA-cleared devices with reported precisions of 100%, 63.2%, and 95.3%.","lead":"SAMD is an automated tool that applies STPA-Sec analysis combined with vulnerability databases and LLMs to detect possible false data injection points in AI/ML medical devices at design time. A smart generalist might read it to see how early-stage security checks could reduce risks of misdiagnosis from tampered medical AI inputs.","discovery_kind":"new_method","skeptic_critique":{"model":"grok-4.3","headline":"Attack scenario relevance (95.3% accuracy) rests on internal author judgment without external feasibility validation","rationale":"The reader's weakest assumption matches the load-bearing point exactly: the realism of LLM-generated scenarios is asserted without external validation. Because the paper's evaluation of the 95.3% figure appears to be author-internal, the concern is unchanged by access to full text. No stronger internal inconsistency (e.g., in the STPA-Sec modeling or vulnerability retrieval logic) is evident from the reported metrics; the evaluation gap is the single point that would most directly affect whether the headline effectiveness numbers can be treated as evidence of practical utility.","tokens_in":1823,"tokens_out":435,"duration_ms":16549,"concrete_test":"Take the 5 case-study devices; extract the 10 highest-scoring attack scenarios from the SAMD output; have two independent medical-device security researchers (unaffiliated with authors) perform a blinded feasibility review against public device documentation and known CVE details, scoring each scenario 1-5 on executability; if mean score <4 or >30% of scenarios rated infeasible due to unaddressed physical or protocol constraints, the 95.3% claim does not establish real-world relevance.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim asserts that SAMD generates 'highly relevant attack scenarios on the ML model, including detailed steps that an adversary might take (with 95.3% accuracy)'. This metric is presented alongside the 100% technology identification and 63.2% vulnerability retrieval results. For the claim that these scenarios are actionable and reflect real adversary capability to hold, the evaluation must demonstrate that the LLM-generated steps are not merely plausible but executable given the device constraints, FDA-cleared architectures, and inference-time data flows described in the STPA-Sec control structure. The abstract and reported results give no indication of blinded external review, red-team execution, or comparison against known real-world incidents beyond the vulnerability database lookup; the accuracy figure therefore functions as an internal plausibility score rather than an externally grounded feasibility measure.","agreement_with_reader":"agree"},"referee_report":{"model":"grok-4.3","summary":"The paper introduces SAMD, a tool that automates STPA-Sec analysis for AI/ML-enabled medical devices by modeling systems as control structures, querying vulnerability databases, and using LLMs to identify false data injection points and generate attack scenarios. Case studies on five FDA-cleared devices claim 100% precision in identifying target device technologies from documentation, 63.2% precision in retrieving linked known vulnerabilities, and 95.3% accuracy in producing highly relevant attack scenarios with detailed adversary steps (maximum runtime 191.64 s).","tokens_in":1979,"tokens_out":493,"duration_ms":21945,"significance":"If the evaluation methodology and external validation were provided and the metrics held under independent review, SAMD would represent a practical contribution to early-stage security analysis for regulated medical devices, where inference-time false data injection risks are difficult to anticipate manually. The combination of formal control-structure modeling with automated vulnerability lookup and scenario generation addresses a real gap in design-phase threat modeling for ML components.","major_comments":[{"comment":"Abstract: The central effectiveness claims rest on three quantitative metrics (100% technology identification precision, 63.2% vulnerability retrieval precision, 95.3% attack-scenario accuracy), yet the abstract supplies no description of the evaluation protocol, ground-truth construction, number of documents or scenarios assessed, blinding procedures, or whether relevance judgments were made solely by the authors versus external red-team reviewers. This omission is load-bearing because the paper's primary contribution is the demonstration of SAMD's utility via these results.","section":"Abstract"},{"comment":"Abstract / Results section: The 95.3% accuracy figure for 'highly relevant attack scenarios' is presented as evidence that the generated steps are actionable for adversaries, but no comparison against known real-world incidents, FDA-cleared device constraints, or STPA-Sec control-structure feasibility is described. Without such grounding, the metric functions as an internal plausibility score rather than a validated feasibility measure.","section":"Abstract"}],"minor_comments":[{"comment":"The timing result (highest time taken 191.64 s) should specify the hardware, LLM model version, and whether the measurement includes database queries or only LLM generation.","section":"Abstract"}],"recommendation":"major_revision","confidential_remarks":null},"author_rebuttal":{"model":"grok-4.3","summary":"We thank the referee for the constructive feedback on the abstract and evaluation details. We address each major comment below and will revise the manuscript accordingly to improve transparency.","responses":[{"response":"We agree the abstract should summarize the evaluation setup. The metrics derive from case studies on five FDA-cleared devices: technology identification used device documentation as ground truth; vulnerability retrieval cross-referenced public databases for known links; scenario relevance was assessed by the authors for alignment with the STPA-Sec control structure and ML false-data-injection potential (no external reviewers or blinding). We will revise the abstract to include a concise description of the protocol, number of devices/scenarios, and judgment basis.","revision_made":"yes","referee_comment":"[Abstract] Abstract: The central effectiveness claims rest on three quantitative metrics (100% technology identification precision, 63.2% vulnerability retrieval precision, 95.3% attack-scenario accuracy), yet the abstract supplies no description of the evaluation protocol, ground-truth construction, number of documents or scenarios assessed, blinding procedures, or whether relevance judgments were made solely by the authors versus external red-team reviewers. This omission is load-bearing because the paper's primary contribution is the demonstration of SAMD's utility via these results."},{"response":"The 95.3% reflects author judgment of scenario relevance to the modeled control structure and ML component constraints. We did not compare to specific real-world incidents, as documented cases for these exact FDA-cleared devices are limited in public literature. The scenarios are explicitly tied to STPA-Sec control actions and retrieved vulnerabilities. We will revise the results section to clarify the metric's internal basis and add an explicit limitations paragraph on the absence of external incident validation.","revision_made":"partial","referee_comment":"[Abstract] Abstract / Results section: The 95.3% accuracy figure for 'highly relevant attack scenarios' is presented as evidence that the generated steps are actionable for adversaries, but no comparison against known real-world incidents, FDA-cleared device constraints, or STPA-Sec control-structure feasibility is described. Without such grounding, the metric functions as an internal plausibility score rather than a validated feasibility measure."}],"tokens_in":1494,"tokens_out":477,"duration_ms":22512,"standing_objections":[]},"desk_editor":{"model":"grok-4.3","letter":"The paper's main contribution is SAMD, a tool that builds a control-structure model of an AI/ML medical device, pulls from vulnerability databases, and uses LLMs to list possible false data injection paths during inference. They ran it on five FDA-cleared devices and report 100% precision on spotting the target technologies in the documents, 63.2% precision on retrieving linked vulnerabilities, and 95.3% accuracy on the generated attack scenarios, with run times under 192 seconds.\n\nWhat the work actually does is automate a security analysis step that is normally manual. The integration of STPA-Sec with LLM scenario generation for this narrow domain is not something I have seen packaged this way before. The case studies give concrete output examples, which is useful for seeing what the tool produces.\n\nThe soft spot is the evaluation of the attack scenarios. The abstract presents the 95.3% figure as accuracy on relevance and detailed steps an adversary might take, yet it gives no account of how that number was obtained, what the ground truth was, or whether anyone outside the author group reviewed the scenarios for executability on the actual device architectures. Without blinded external review or red-team execution, the number functions as an internal plausibility score rather than a demonstrated feasibility measure.\n\nThe paper is aimed at security engineers and regulators who need design-phase tools for AI medical devices. Readers already working on STPA or LLM-assisted threat modeling will see the most direct value.\n\nI would send it to peer review so the methods section and any additional validation can be examined in detail.","headline":"SAMD puts STPA-Sec and LLMs together for false-data-injection analysis on medical devices, but the 95.3% scenario relevance rests on internal judgment with no external check described.","tokens_in":2505,"tokens_out":406,"would_cite":false,"duration_ms":17399,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.3","headline":"SAMD automates identification of false data injection risks in AI/ML medical devices by modeling them as control structures and using vulnerability databases with language models.","keywords":["false data injection","AI security","medical devices","attack scenario generation","vulnerability analysis","control structure modeling","FDA-cleared devices","automated security tool"],"falsifier":"An independent red-team test on one of the five case-study devices in which security experts attempt the scenarios produced by SAMD and report how many succeed or match the generated steps.","tokens_in":2723,"feed_emoji":"🛡️","tokens_out":709,"duration_ms":23748,"temperature":0.7,"pith_summary":"The paper introduces SAMD to perform security analysis on AI-enabled medical devices at the design stage, before users assemble the full system. It treats every component as a possible entry point for feeding false data into the machine learning engine, which could lead to misdiagnosis. The tool pulls known vulnerabilities from databases and uses language models to produce detailed lists of attack scenarios an adversary might follow. This approach matters because many risks only become visible once devices are in actual use. If the method works as described, device makers could spot and close injection paths earlier in development.","feed_headline":"Tool spots false data risks in AI medical devices","feed_subtitle":"SAMD models each device as a control structure and uses databases plus language models to list injection paths, shown effective on five FDA-","key_machinery":"The SAMD tool that represents the medical device as a control structure, treats every component as a possible false-data entry point into the ML model, and automates vulnerability lookup plus attack-scenario generation through databases and language models.","core_discovery":"SAMD models the medical system as a control structure in which all components are potential points for injecting false data into the ML engine. It combines vulnerability databases with large language models to automate discovery of weaknesses and to generate lists of potential attack scenarios that include concrete steps an adversary could take. Case studies on five FDA-cleared devices show the tool identifies target device technologies with 100 percent precision, retrieves linked known vulnerabilities with 63.2 percent precision, and produces highly relevant attack scenarios with 95.3 percent accuracy.","pith_inferences":["The same control-structure modeling could be applied to other safety-critical AI systems that combine hardware and software at deployment time.","Regulatory bodies might incorporate automated scenario lists as part of pre-market security reviews for AI medical devices.","Connecting the output directly to patch-management systems could shorten the time between scenario discovery and mitigation.","Extending the approach to include runtime monitoring data might allow ongoing updates to the attack scenario list after deployment."],"forward_implications":["Device designers can locate vulnerable points and injection paths into the ML model before the system reaches end users.","Detailed adversary steps for each scenario become available automatically during the design phase.","Known vulnerabilities tied to specific device technologies are surfaced for review with measurable retrieval rates.","The same process scales across multiple FDA-cleared devices without manual re-analysis of each component."],"fun_headline_variants":["SAMD identifies false data injection in AI/ML medical devices","SAMD models control structures to find injection attack scenarios","LLM and database tool automates security analysis for medical AI","Tool generates attack paths for FDA-cleared AI medical devices"],"cache_read_input_tokens":2112,"weakest_assumption_plain":"The generated attack scenarios accurately reflect what real adversaries could achieve, based on the authors' assessment of relevance rather than separate external testing.","fun_headline_variants_meta":{"raw":{"variants":["SAMD identifies false data injection in AI/ML medical devices","SAMD models control structures to find injection attack scenarios","LLM and database tool automates security analysis for medical AI","Tool generates attack paths for FDA-cleared AI medical devices"]},"model":"grok-4.3","cost_usd":0.005179,"raw_usage":{"total_tokens":2548,"prompt_tokens":738,"num_sources_used":0,"completion_tokens":66,"cost_in_usd_ticks":51787000,"prompt_tokens_details":{"text_tokens":738,"audio_tokens":0,"image_tokens":0,"cached_tokens":256},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":1744,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":738,"tokens_out":66,"duration_ms":15050,"temperature":1.0,"reasoning_tokens":1744,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-06-29T07:13:37.206764+00:00","model_set":{"reader":"grok-4.3"},"falsifier":"An independent red-team test on one of the five case-study devices in which security experts attempt the scenarios produced by SAMD and report how many succeed or match the generated steps.","supporting_citations":[],"review_version":1}